The amyotrophic lateral sclerosis market is projected to grow from USD 835.8 million in 2025 to USD 1,496.9 million by 2035, at a CAGR of 6.0%. Medication will dominate with a 54.7% market share, while hospital pharmacies will lead the distribution channel segment with a 62.3% share.